Study limitation: The study excluded immunocompromised patients and those with orbital cellulitis or clinical toxicity, so findings may not apply to higher-risk subgroups | ReachRx
External validation of the Melbourne ASSET score for pediatric cellulitis
Study limitation reported by the research below: “The study excluded immunocompromised patients and those with orbital cellulitis or clinical toxicity, so findings may not apply to higher-risk subgroups.”